BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 19, 2014
View Archived Issues
Otsuka Pharmaceutical recaps highlights of second quarter of fiscal 2014
Read More
Trevena releases data from phase IIa/b study of TRV-130 in acute postoperative pain
Read More
ObsEva initiates phase II trial of oxytocin receptor antagonist in women undergoing embryo transfer
Read More
Wilson Therapeutics begins phase II study of WTX-101 in Wilson disease
Read More
Validation of the antifibrogenic activity of a peripherally restricted CB1 antagonist
Read More
First possible biomarker for liver disease in alpha-1 antitypsin deficiency identified
Read More
RALDH 1 explored as a target for treating obesity and diabetes
Read More
Trumenba launched in the U.S.
Read More
JCAR-015 leukemia T-cell therapy granted FDA orphan drug designation
Read More
Hemispherx's Ampligen blocks critical Ebola viral disease viral protein
Read More
P-11520031, a novel T-type calcium channel blocker for neuropathic pain
Read More
German organization reports development of anti-parasitic vaccines
Read More
The Vanderbilt University patents detail novel mAChR M1 PAMs
Read More
Ajinomoto patents glycogen synthase activators
Read More
Chong Kun Dang Holdings patent divulges novel HDAC6 inhibitors
Read More
Roche discloses new CB2 receptor agonists
Read More
Preclinical pharmacology, safety and activity profiling of dual JAK3/ITK inhibitor ARN-4079
Read More
Consortium readied to advance development of MicroNeurotrophins for ALS
Read More
Actavis completes tender offer for Durata Therapeutics
Read More
Investigators develop DNA-based vaccine against Leishmaniasis infection
Read More
Inderal approved in Japan for the inhibition of onset of hypoxic spell in RVOTO
Read More
Long-acting anticholinergic drug to treat bronchial asthma approved in Japan
Read More
Arrowhead Research seeks clearance for phase I trial of ARC-AAT for AAT deficiency
Read More
Reckitt Benckiser plans to spin off pharmaceuticals business into Indivior
Read More
European Commission grants marketing authorization to Harvoni
Read More